CDH2 and breast cancer: Through comparison and integration, we obtained three axes that relate to the treatment and prognosis of BC, namely, LINC00466-Hsa-mir-204-TGFBR2, LINC00466-Hsa-mir-204-CDH2, and LINC00466-Hsa-mir-204-CHRDL1.